Microwave-generated bionanocomposites

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 1, 2013, Pages 79-93

  Kushare, Sachin Shivaji ^a   Gattani, Surendra G ^b  

^a R G Sapkal College of Pharmacy   (India)

^b SWAMI RAMANAND TEERTH MARATHWADA UNIVERSITY   (India)

Author keywords

BCS class II drug; bionanocomposites; glipizide; microwave induced diffusion; natural carriers

Indexed keywords

BIONANOCOMPOSITE; CASSIA GUM; DRUG CARRIER; GELATIN; GHATTI GUM; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; GUM ARABIC; NANOCARRIER; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; FOAMING INDEX; GLUCOSE BLOOD LEVEL; GREEN CHEMISTRY; HYPERGLYCEMIA; IMMEDIATE RELEASE TABLET; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MICROWAVE INDUCED DIFFUSION; MICROWAVE RADIATION; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POWDER; PROCESS OPTIMIZATION; RAT; SCANNING ELECTRON MICROSCOPY; TABLET COMPRESSION; TABLET FORMULATION; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; WETTABILITY;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLIPIZIDE; GREEN CHEMISTRY TECHNOLOGY; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; KINETICS; MALE; MICROWAVES; NANOCOMPOSITES; RATS; RATS, WISTAR; SOLUBILITY; SURFACE-ACTIVE AGENTS; VISCOSITY;

EID: 84870878399     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01584.x     Document Type: Article

References (38)

1. Rabinow BE,. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004; 9: 785-796.
2. Kadu PJ, et al,. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol 2011; 1: 65-74.
3. Amidon GL, et al,. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 3: 413-420.
4. Liu R,. Water-insoluble drug formulation, 2nd edn. Boca Raton, FL: CRC Press, 2008.
5. Dressman JB, Reppas C,. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci 2000; 11 (Suppl. 2): S73-S80.
6. Hornyak GL, et al,. Materials, structure and the nanosurface. Introduction to Nanoscience, 3rd edn. New York: CRS Press, 2008.
7. Colombo I, et al,. Drug mechanochemical activation. J Pharm Sci 2009; 11: 3961-3986.
8. Muller RM, Akkar A,. Drug nanocrystals of poorly soluble drugs. Encyclop Nanosci Nanotechnol 2004; 2: 627-638.
9. Keck CM, Muller RH,. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 2006; 1: 3-16.
10. Ali HS, et al,. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm 2009; 1-2: 107-113.
11. Mohanraj VJ, Chen Y,. Nanoparticles-a review. Trop J Pharm Res 2006; 1: 561-573.
12. Pathak P, et al,. Supercritical fluid technology for enhanced drug delivery. Expert Opin Drug Deliv 2005; 4: 747-761.
13. Kumar CSSR,. Biological and Pharmaceutical Nanomaterials, Nanotechnologies for the Life Sciences, 1st edn. Weinheim: Wiley-VCH, 2006.
14. Adamson AW, Gast AP,. Physical Chemistry of Surfaces, 6th edn. New York: Wiley, 1997.
15. Hill TL,. A different approach to nanothermodynamics. Nano Lett 2001; 1: 273-275.
16. Kesisoglou F, et al,. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007; 7: 631-644.
17. Merisko-Liversidge E, et al,. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm Res 1996; 2: 272-278.
18. Grau MJ, et al,. Nanosuspensions of poorly soluble drugs-reproducibility of small scale production. Int J Pharm 2000; 2: 155-159.
19. Abdelwahed W, et al,. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev 2006; 15: 1688-1713.
20. Ploehn HJ, Russell WB,. Interactions between colloidal particles and soluble polymers. Adv Chem Eng 1990; 15: 137-228.
21. Bergese P, et al,. Microwave generated nanocomposites for making insoluble drugs soluble. Mater Sci Eng C 2003; 6-8: 791-795.
22. Wong TW,. Use of microwave in processing of drug delivery systems. Curr Drug Deliv 2008; 5: 77-84.
23. Papadimitriou AS, et al,. Microwave-induced enhancement of the dissolution rate of poorly water-soluble tibolone from poly(ethylene glycol) solid dispersions. J Appl Polym Sci 2008; 108: 1249-1258.
24. Kerc J, et al,. Alternative solvent-free preparation methods for felodipine surface solid dispersions. Drug Dev Ind Pharm 1998; 4: 359-363.
25. Patel M, et al,. Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech 2008; 4: 1262-1269.
26. Thakral S, Madan AK,. Urea co-inclusion compounds of glipizide for the improvement of dissolution profile. J Inclusion Phenom Macrocyclic Chem 2007; 3-4: 203-209.
27. Murali Mohan Babu GV, et al,. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J Pharm 2002; 1-2: 1-17.
28. Belgamwar VS, et al,. Formulation and evaluation of in situ gelling system of dimenhydrinate for nasal administration. Pharm Dev Technol 2009; 3: 240-248.
29. The United States Pharmacopoeia 30-National Formulary 25. Rockville, MD: US Pharmacopoeial Convention Inc., 2007.
30. Wagner JG,. Biopharmaceutics and Relevant Pharmacokinetics, 1st edn. Hamilton, IL: Drug Intelligence Publications, 1971.
31. Higuchi T,. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961; 50: 874-875.
32. Korsmeyer RW, et al,. Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics 1983; 1: 25-35.
33. Hixson A, Crowell J,. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem 1931; 8: 923-931.
34. U.S.P. USP 30, NF 27. 1,2,3: Rockvillle, MD: United States Pharmacopeial Convention, 2007.
35. Khan K,. The concept of dissolution efficiency. J Pharm Pharmacol 1975; 1: 48-49.
36. Zhang R, et al,. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J Ethnopharmacol 2004; 1: 39-43.
37. Murali Mohan Babu G, et al,. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J Pharm 2002; 1-2: 1-17.
38. Brunton LL,. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 694: New York: McGraw-Hill, 2006.